Exagen (XGN)
Develops AVISE tests for diagnosis and monitoring of autoimmune disease.
$8.74
After hours−0.02 (−0.23%)
At close$8.76(+1.62%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 32.81% | 7.95M shares | |
|---|---|---|---|
| 57 holders · as of Jun 30, 2026 | |||
| Insiders | 14.77% | 3.58M shares | |
| 3 holders · as of Sep 2, 2026 | |||
| Strategic holders | 5.65% | 1.37M shares | |
| 1 holder · as of Feb 11, 2026 | |||
| Other | 46.77% | 11.33M shares | |
| remainder | |||
24.23M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
57 holders · 7.95M shares · 8 new positions · 23 increased · 24 reduced · 12 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Wexford Capital LP | 792.9K | 3.27% | 0 | Aug 14, 2026 |
| Nano Cap New Millennium Growth Fund L P | 675.0K | 2.79% | +90.0K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 612.8K | 2.53% | −65.8K | Aug 13, 2026 |
| Fourworld Capital Management LLC | 596.5K | 2.46% | +156.6K | Aug 14, 2026 |
| Silvercrest Asset Management Group LLC | 514.8K | 2.12% | −23.1K | Aug 14, 2026 |
| Kennedy Capital Management LLC | 485.0K | 2.00% | −8.6K | Aug 14, 2026 |
| Mink Brook Asset Management LLC | 475.9K | 1.96% | +106.9K | Aug 14, 2026 |
| Jane Street Group, LLC | 322.5K | 1.33% | +85.8K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Chernett Jorey | 9.90% | 2.41M | 13G | May 20, 2026 |
| NMSIC Co-Investment Fund, L.P. | 6.04% | 1.37M | 13G | Feb 11, 2026 |
| Parian Ultreia LP | 5.30% | 1.29M | 13G | May 27, 2026 |
| Cowen Financial Products LLC | 5.00% | 891.4K | 13G | May 12, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 1, 2026 | Jeffrey G. Blackofficer: Chief Financial Officer | Sale | 20,614 | $7.22 | 323,339 |
| Mar 3, 2026 | John Aballidirector, officer: President and CEO | Sale | 15,698 | $3.62 | 687,299 |
| Feb 24, 2026 | Jeffrey G. Blackofficer: Chief Financial Officer | Sale | 1,584 | $3.61 | 267,442 |
| Feb 24, 2026 | John Aballidirector, officer: President and CEO | Sale | 11,430 | $3.61 | 702,997 |
| Oct 16, 2025 | John Aballidirector, officer: President and CEO | Sale | 31,787 | $11.82 | 714,427 |
House and Senate disclosures
Not reported.